Bio-Thera Solutions Ltd - Asset Resilience Ratio

Latest as of December 2024: 4.09%

Bio-Thera Solutions Ltd (688177) has an Asset Resilience Ratio of 4.09% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Bio-Thera Solutions Ltd (688177) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥90.22 Million

≈ $13.20 Million USD Cash + Short-term Investments

Total Assets

CN¥2.21 Billion

≈ $322.74 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Bio-Thera Solutions Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Bio-Thera Solutions Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down Bio-Thera Solutions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Bio-Thera Solutions Ltd (688177) financial obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥90.22 Million	4.09%
Total Liquid Assets	CN¥90.22 Million	4.09%

Asset Resilience Insights

Limited Liquidity: Bio-Thera Solutions Ltd maintains only 4.09% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bio-Thera Solutions Ltd Industry Peers by Asset Resilience Ratio

Compare Bio-Thera Solutions Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Abivax SA PA:ABVX	Biotechnology	2.58%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Lifecome Biochemistry Co Ltd SHE:002868	Biotechnology	4.69%
Pulike Biological Engineering SHG:603566	Biotechnology	17.82%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	14.00%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Upstream Bio, Inc. NASDAQ:UPB	Biotechnology	64.70%

Annual Asset Resilience Ratio for Bio-Thera Solutions Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Bio-Thera Solutions Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.09%	CN¥90.22 Million ≈ $13.20 Million	CN¥2.21 Billion ≈ $322.74 Million	-10.38pp
2023-12-31	14.47%	CN¥331.03 Million ≈ $48.44 Million	CN¥2.29 Billion ≈ $334.67 Million	-14.42pp
2022-12-31	28.90%	CN¥629.89 Million ≈ $92.17 Million	CN¥2.18 Billion ≈ $318.96 Million	+5.87pp
2021-12-31	23.03%	CN¥602.83 Million ≈ $88.21 Million	CN¥2.62 Billion ≈ $383.06 Million	-16.91pp
2020-12-31	39.94%	CN¥955.77 Million ≈ $139.86 Million	CN¥2.39 Billion ≈ $350.19 Million	--

pp = percentage points

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.28 Billion

CN¥8.74 Billion CNY

Market Cap Rank

#7926 Global

#1817 in China

Share Price

CN¥21.10

Change (1 day)

+8.99%

52-Week Range

CN¥16.10 - CN¥29.53

All Time High

CN¥71.90